https://pharmoniq.com/news/gsk-dostarlimab-sustained-responses-dmmr-msi-high-cancers PharmoniQ en 2026-07-14T08:47:02.849Z GSK's Dostarlimab Shows Sustained Responses in dMMR/MSI-H Cancers immunotherapy, dostarlimab, precision oncology, biomarkers, GSK https://pharmoniq.com/news/joint-supplement-alzheimers-risk-new-research PharmoniQ en 2026-07-13T14:10:49.952Z Popular Joint Supplement Linked to Alzheimer's Risk in New Research joint supplements, Alzheimer's disease, supplement safety, cognitive health, FDA regulation https://pharmoniq.com/news/uq-breakthrough-immune-receptor-mnd-treatment PharmoniQ en 2026-07-12T14:10:49.971Z UQ Researchers Crack 'Undruggable' Immune Target for MND Treatment motor neurone disease, MND, drug discovery, immune receptors, neurodegeneration